Atrial fibrillation and stroke risk prevention in real-life clinical practice

Thromb Haemost. 2009 Mar;101(3):415-6.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use*
  • Aspirin / administration & dosage
  • Aspirin / therapeutic use*
  • Atrial Fibrillation / complications*
  • Chronic Disease
  • Clinical Trials as Topic
  • Female
  • Humans
  • International Normalized Ratio
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Risk
  • Stroke / etiology
  • Stroke / prevention & control*
  • Time Factors
  • Warfarin / administration & dosage
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Platelet Aggregation Inhibitors
  • Warfarin
  • Aspirin